A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2001
12/26/2001	CN1076606C Use of novel steroid esters for preparing medicaments flammatory and anti-allergic activity
12/26/2001	CA2351215A1 Use of ergothioneine and/or its derivatives as an antiglycation agent
12/25/2001	US6333399 Preparing preferential binding particles; mix chitin containing microorganism in alkaline solution, mix with mineral acid, mix with second mineral acid solution, neutralize and recover binding particles
12/25/2001	US6333361 Pharmaceutical composition containing zafirlukast
12/25/2001	US6333356 Compounds for treating skin conditions
12/25/2001	US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics
12/25/2001	US6333325 Method of treating cytokine mediated diseases or conditions
12/25/2001	US6333324 For therapy and prophylaxis of matrix metalloproteinases (mmp) or tumor necrosis factor .alpha. (tnf.alpha.), mediated diseases
12/25/2001	US6333319 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof
12/25/2001	US6333054 Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
12/25/2001	US6333041 Nontoxic vernix compositions and method of producing
12/25/2001	US6333027 Non-stinging to the eyes
12/25/2001	CA2186775C Ribosome fraction and composition containing the same
12/25/2001	CA2172779C Cgrp antagonist used for the treatment of pruritus and ocular or palpebral dysesthesia
12/25/2001	CA2166517C Cosmetic or dermatologic composition containing at least a ceramide 6
12/20/2001	WO2001096603A2 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
12/20/2001	WO2001096547A2 Human kinases
12/20/2001	WO2001096546A2 Protein phosphatases
12/20/2001	WO2001096461A1 Polysaccharide based gel
12/20/2001	WO2001096397A2 Cd154 variants and uses thereof
12/20/2001	WO2001096347A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
12/20/2001	WO2001096343A1 Substituted metal-phthalocyanines, their preparation and the use thereof
12/20/2001	WO2001096336A2 6,5-fused bicyclic heterocycles
12/20/2001	WO2001096323A1 Serine protease inhibitors
12/20/2001	WO2001096322A1 Diamino phenothiazine derivatives and composition comprising same
12/20/2001	WO2001096310A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
12/20/2001	WO2001096305A1 Serine protease inhibitors
12/20/2001	WO2001096300A1 Growth hormone secretagogues
12/20/2001	WO2001096299A2 Indole derivatives and their use as 15-lipoxygenase inhibitors
12/20/2001	WO2001096298A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
12/20/2001	WO2001096296A1 Serine protease inhibitors
12/20/2001	WO2001096293A1 Vitamin d derivatives
12/20/2001	WO2001095935A1 Immunostimulatory nucleic acids for inducing a th2 immune response
12/20/2001	WO2001095928A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion
12/20/2001	WO2001095926A1 Immunosuppressor agent derived from morbillivirus
12/20/2001	WO2001095894A2 Topical water-based anti-inflammatory compositions
12/20/2001	WO2001095890A2 Oral pharmaceutical compositions containing terbinafine
12/20/2001	WO2001095873A1 Hand treatment lotion
12/20/2001	WO2001095872A1 Cosmetic and/or dermatological composition based on cocoa extracts
12/20/2001	WO2001095859A2 Novel heterocyclic analogs of diphenylethylene compounds
12/20/2001	WO2001095710A1 Caspase 1 gene transfer animal
12/20/2001	WO2001066550A3 Compounds for pdt
12/20/2001	WO2001058896A8 Benzoxazole derivatives as tnf and pde iv inhibitors
12/20/2001	WO2001056554A3 Use of retinoid-type compounds as antibacterial agents
12/20/2001	WO2001050872A3 Method for produce sanitation using bacteriophages
12/20/2001	WO2001049689A3 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
12/20/2001	WO2001031016A3 Processed human chemokines phc-1 and phc-2
12/20/2001	WO2001019770A3 Rxr modulators with improved pharmacologic profile
12/20/2001	WO2001016108A3 Bicyclic androgen and progesterone receptor modulator compounds and methods
12/20/2001	US20010053853 Alkanoic acid derivative; integrin receptor antagonist
12/20/2001	US20010053844 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
12/20/2001	US20010053800 Long chain monounsaturated alcohol mixtures
12/20/2001	US20010053782 Pyrrolo[2,3-d]pyrimidine compounds
12/20/2001	US20010053771 Topical
12/20/2001	US20010053764 Interleukin-1 inhibitors in the treatment of diseases
12/20/2001	US20010053763 Method and composition for modulating an immune response
12/20/2001	US20010053759 Skin cancer preventive agent
12/20/2001	US20010053363 Novel amphipathic aldehydes and their uses as adjuvants and immunoeffectors
12/20/2001	US20010053357 Peptide having an amino acid sequence corresponding to an amino acid sequence of a V-domain of a receptor for advanced glycation endproduct.
12/20/2001	US20010053351 Inhibition of GSK-3 beta
12/20/2001	US20010053350 Cosmetic composition comprising N-ethyloxycarbonyl-4-amino-phenol and arbutin or its derivatives and/or ellagic acid or its derivatives
12/20/2001	US20010053347 Methods and compositions for preventing and treating chronological aging in human skin
12/20/2001	CA2412632A1 Hmg-coa reductase inhibitors and method
12/20/2001	CA2412579A1 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
12/20/2001	CA2412462A1 6,5-fused bicyclic heterocycles
12/20/2001	CA2412356A1 Immunosuppressor agent derived from morbillivirus
12/20/2001	CA2411962A1 Methods for regulating a cell-mediated immune response by blockinglymphocytic signals and by blocking lfa-1 mediated adhesion
12/20/2001	CA2411805A1 Serine protease inhibitors
12/20/2001	CA2411798A1 Serine protease inhibitors
12/20/2001	CA2411495A1 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
12/20/2001	CA2411472A1 Cd154 variants
12/20/2001	CA2411116A1 Indole derivatives and their use as 15-lipoxygenase inhibitors
12/20/2001	CA2410824A1 Diamino phenothiazine derivatives and composition comprising same
12/20/2001	CA2410610A1 Human kinases
12/20/2001	CA2410171A1 Novel heterocyclic analogs of diphenylethylene compounds and uses thereof
12/20/2001	CA2409315A1 Protein phosphatases
12/20/2001	CA2408575A1 Cosmetic and/or dermatological composition based on cocoa extracts
12/20/2001	CA2396871A1 Immunostimulatory nucleic acids for inducing a th2 immune response
12/20/2001	CA2351275A1 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
12/19/2001	EP1164135A1 Substituted metal-phthalocyanines, their preparation and the use thereof
12/19/2001	EP1163905A1 Skin preparations for external use
12/19/2001	EP1163528A2 Prediction of diabetes impaired wound healing
12/19/2001	EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites
12/19/2001	EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
12/19/2001	EP1163332A1 48 human secreted proteins
12/19/2001	EP1163331A1 50 human secreted proteins
12/19/2001	EP1163274A1 Process for cross-linking hyaluronic acid to polymers
12/19/2001	EP1163271A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
12/19/2001	EP1163255A1 50 human secreted proteins
12/19/2001	EP1163249A1 Bioprecursors of a retinoic derivative and pharmaceutical and/or cosmetic compositions
12/19/2001	EP1163242A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
12/19/2001	EP1163239A1 Modified amino-acid amides as cgrp antagonists
12/19/2001	EP1163238A1 Chemokine recpetor binding heterocyclic compounds
12/19/2001	EP1163237A1 Amide derivatives
12/19/2001	EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents
12/19/2001	EP1163227A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
12/19/2001	EP1163226A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
12/19/2001	EP1163225A1 Compounds and methods for modulation of estrogen receptors
12/19/2001	EP1163214A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
12/19/2001	EP1163213A1 Hydroxamic and carboxylic acid derivatives

1 ... 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 ... 1065